Medicinova (MNOV) EBT Margin (2012 - 2026)
Medicinova (MNOV) posted quarterly EBT Margin of 1841.01% for Q4 2025, up 29.37% quarter-over-quarter from 2606.72% in Q3 2025.
Medicinova (MNOV) EBT Margin (2012 - 2026) Analysis & Trends
Medicinova (MNOV) has reported EBT Margin for 5 consecutive years, with 1841.01% the latest figure, recorded in Q4 2025.
- In Q4 2025, EBT Margin changed N/A year-over-year to 1841.01%; the TTM figure through Dec 2025 stood at 3142.14% (changed N/A YoY), while the FY2025 annual figure was 2927.32%, changed N/A from the prior year.
- EBT Margin climbed to 1841.01% in Q4 2025 per MNOV's latest filing, from 2606.72% in the prior quarter.
- Across five years, EBT Margin topped out at 5.66% in Q1 2021 and bottomed at 12464.77% in Q3 2021.
- Historically, EBT Margin has averaged 3291.35% across 3 years, with a median of 2223.86% in 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Medicinova | 66.94 Mn | 66.94 Mn | 317,759.00 | -503.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -530.09% |
| Dec 31, 2025 | -1,841.01% |
| Sep 30, 2025 | -2,606.72% |
| Jun 30, 2025 | -2,681.41% |
| Sep 30, 2023 | -148.54% |
| Sep 30, 2021 | -12,464.77% |
| Mar 31, 2021 | -5.66% |
| Dec 31, 2013 | 56.92% |
| Jun 30, 2013 | -1,083,361.87% |
| Mar 31, 2013 | -80,675.30% |
| Dec 31, 2012 | -7,249.47% |
| Sep 30, 2012 | -2,824.94% |
| Jun 30, 2012 | -461.81% |
| Mar 31, 2012 | -2,024.72% |